AIDS Vaccine

Study shows promising results for development of preventive vaccine

Published in Vaccine Weekly, July 17th, 2002

The Immune Response Corporation (IMNR) announced results of a study published in the journal Vaccine (2002;20(21-22):2684-2692), which suggested a combination of Remune and immunostimulatory DNA was able to shift the immune response from an antibody mediated response (Th2) to a cell-mediated response (Th1) in mice infected with the parasite Schistosoma.

In the test, mice infected with Schistosoma were immunized with Remune and CpG ODN immunostimulatory DNA and showed significantly lower levels of Th2 related substances and increased levels of Th1 related substances such as the cytokine (gamma) interferon.

According to the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2002-07-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry